🇺🇸 FDA
Pipeline program

mycophenolate mofetil 2 g per day

122

Phase 3 small_molecule completed

Quick answer

mycophenolate mofetil 2 g per day for Lymphocytic Myocarditis (Disorder) is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Lymphocytic Myocarditis (Disorder)
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials